title: [Plasma malondialdehyde in patients with type 2 diabetes mellitus and in patients with coronary disease].
abstract: After intracoronary platelet aggregation, malondialdehyde (MDA), a lipid peroxide product is released. MDA renders some lipoproteins more atherogenic.
  
  
  OBJECTIVE
  The objective of this study was to determine the sanguineous concentration of MDA in patients with type 2 diabetes mellitus (DM2) and patients with coronary disease. We measured methods and material MDA in plasma of 131 consecutive normal subjects, 44 hyperlipidemic, hyperglycemic patients with type 2-diabetes mellitus (DM2), 60 normolipidemic patients with angina, and 62 normolipidemic patients with acute myocardial infarction with and without DM2.
  
  
  METHODS
  The concentration of MDA was lowest in normal subjects (42.5 +/- 7.2 micrograms per deciliter), intermediate in those with DM2 (62.7 +/- 10.1 micrograms per deciliter, p < 0.002), and highest in those with myocardial infarction (101.6 +/- 31.7 micrograms per deciliter, p < 0.001). The mean MDA concentration of patients with infarction was similar to that of patients with angina (121.8 +/- 51.9 micrograms per deciliter, p < 0.07). Stepwise logistic regression analysis showed that MDA was a possible predictor of myocardial infarction.
  
  
  CONCLUSIONS
  The increase of plasma MDA might be a biochemical marker of coronary artery disease. We suggest that MDA levels greater than 62.7 micrograms per deciliter could indicate a high risk for myocardial infarction.
authors.affiliation: Unidad de Investigación Médica (UIM) en Enfermedades Oncológicas, Hospital de Especialidades, México, D.F.
authors.forename: M
authors.initials: M
authors.lastname: Rábago-Velasco
authors.forename: H
authors.initials: H
authors.lastname: Cortez-Valero
authors.forename: E
authors.initials: E
authors.lastname: Aguilar-Parada
authors.forename: H
authors.initials: H
authors.lastname: Arellano-Pérez
authors.forename: C
authors.initials: C
authors.lastname: Vázquez-Chávez
authors.forename: M
authors.initials: M
authors.lastname: Jiménez-Villarruel
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001786:Blood Glucose / Q000032:analysis; D003327:Coronary Disease / Q000097:blood*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D008315:Malondialdehyde / Q000097:blood*; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood*
chemical_list: D001786:Blood Glucose; D008315:Malondialdehyde